13F-HR filed by Commodore Capital LP
Commodore Capital LP filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 33 holding rows worth $1,678,964,770.
- Accession
- 0001831942-26-000033
- Filer
- CIK 1831942
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 33 entries on the cover page, a total value of $1,678,964,770 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,678,964,770 with VALUE read as dollars as filed, 13F file number 028-20976. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 12,000,000 | $224,520,000 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 3,275,000 | $166,206,250 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 3,000,000 | $157,185,000 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 3,050,000 | $118,035,000 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 5,650,000 | $101,474,000 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 2,000,000 | $94,080,000 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 846,786 | $75,177,661 | dollars as filed | |
| ALTO NEUROSCIENCE INC COM SHS | 02157Q109 | Stock | 2,723,196 | $71,865,142 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 2,250,000 | $70,335,000 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 4,600,000 | $65,780,000 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 1,875,000 | $59,887,500 | dollars as filed | |
| DAMORA THERAPEUTICS INC | 36322Q206 | COMMON STOCK | 1,939,000 | $50,433,390 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 1,350,000 | $50,233,500 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 1,425,000 | $49,276,500 | dollars as filed | |
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 1,500,000 | $48,682,500 | dollars as filed | |
| ASSEMBLY BIOSCIENCES INC | 045396207 | COMMON STOCK | 1,415,000 | $38,884,200 | dollars as filed | |
| EDITAS MEDICINE INC | 28106W103 | COM | 8,889,000 | $28,800,360 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 250,000 | $28,667,500 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 6,336,782 | $21,608,427 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 8,695,652 | $21,304,347 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 3,250,000 | $19,175,000 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 1,018,319 | $18,818,535 | dollars as filed | |
| Inflarx Nv | N44821101 | COM | 7,300,000 | $16,352,000 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 2,933,680 | $14,199,011 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 100,000 | $12,350,000 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 2,870,000 | $11,193,000 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 5,397,488 | $10,956,901 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 1,425,000 | $9,861,000 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 4,475,000 | $8,055,000 | dollars as filed | |
| Research Alliance Corp Iii Ord Shs Cl A | G75226103 | Common Stock | 500,000 | $5,350,000 | dollars as filed | |
| HELIX ACQUISITION CORP III | G4444S107 | USD CL A ORD SHS | 500,000 | $5,320,000 | dollars as filed | |
| LeonaBio Inc | 04746L203 | COM | 464,398 | $4,267,818 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 2,788,620 | $630,228 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001831942-26-000033 | this filing | 2026-08-14 | acceptance time not in the bulk data set |